Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial
PloS one, Volume 8, Issue 3, 2013, Pages e56400-e56400.
Antiretroviral prophylaxis may be a critical strategy to reduce periconception HIV transmission. Maximizing the benefit of periconception pharmacologic HIV risk-reduction requires an understanding of the links between pregnancy and adherence to this prevention strategy.We assessed study gel adherence among women with pregnancies compared ...More
Full Text (Upload PDF)